Skip to content

Vaginal Atrophy Treatment Using Microablative Fractional Carbon Dioxide Laser: A Randomized Patient and Evaluator-Blinded Sham-Controlled Trial

Vaginal Atrophy Treatment Using Microablative Fractional Carbon Dioxide Laser: A Randomized Patient and Evaluator-Blinded Sham-Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160627002
Enrollment
88
Registered
2016-06-27
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal atrophy Fractional carbon dioxide laser Vaginal atrophy Postmenopausal women

Interventions

Patients will receive vaginal microablative fractional CO2 laser treatment for 3 sessions every 4 weeks interval using laser system(SmartXide2 V2LR&#44
Italy). The vaginal laser probe will be inserted into the total length of vagina and subsequently withdrawn for every 0.5 centimeters following each laser beam application until the distal end of vagi
Experimental Device,Sham Comparator Device
vaginal microablative fractional carbon dioxide laser,sham procedure

Sponsors

THE 90TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND ( Ratchadaphiseksomphot Endowment Fund)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women attending Gynecology outpatient clinic, King Chulalongkorn Memorial Hospital 2. Having symptoms and signs of vaginal atrophy with moderate to severe intensity 3. Age 50 years 4. Absence of menstruation for at least 12 months

Exclusion criteria

Exclusion criteria: 1. Using of any hormonal treatment within 6 months 2. Using vaginal moisturizers, lubricants or any local preparation within 30 days 3. Having narrow introitus less than 2 cms(vaginal probe size) 4. Women who have never had sexual intercourse 5. Having acute or recurrent urinary tract infection 6. Having active genital infection(e.g. herpes genitalis, vaginal candidiasis) 7. Having pelvic organ prolapse stage 2 according to POP-Q classification(25) 8. Having previous pelvic reconstruction surgery 9. Having any serious medical condition that could interfere with study compliance

Design outcomes

Primary

MeasureTime frame
Vaginal Health Index Score every 4 weeks determine 5 signs of vaginal atrophy by inspection and pH testing

Secondary

MeasureTime frame
Vaginal Atrophy Symptom(VAS) score every 4 weeks interview for assessment of intensity of vaginal atrophy symptoms ,vaginal symptom related to vaginal atrophy every 4 weeks complete the ICIQ-VS questionnaire,quality of life related to vaginal atrophy every 4 weeks complete of SF-12 questionnaire

Countries

Thailand

Contacts

Public ContactPurim Ruanphoo

Chulalongkorn University

prmrnph2011@gmail.com0818880728

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026